Warberg Asset Management’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,200
Closed -$1.09K 246
2023
Q1
$1.09K Hold
18,200
﹤0.01% 246
2022
Q4
$1.46K Hold
18,200
﹤0.01% 257
2022
Q3
$7K Sell
18,200
-4,800
-21% -$2.09K ﹤0.01% 249
2022
Q2
$13K Buy
+23,000
New +$22.7K ﹤0.01% 198
2022
Q1
Sell
-43,603
Closed -$37K 233
2021
Q4
$37K Sell
43,603
-41,544
-49% -$42.1K 0.01% 157
2021
Q3
$98K Buy
85,147
+75,147
+751% +$101K 0.02% 139
2021
Q2
$14K Buy
+10,000
New +$12K ﹤0.01% 193

Other funds holding CELUW

Warberg Asset Management's CELUW Position: Q2 2023 in Review

Warberg Asset Management sold out of Celularity Inc (CELUW) in Q2 2023, closing a stake of 18,200 shares — an estimated $1.09K sold.

Warberg Asset Management first reported a position in CELUW in Q2 2021 and held it in 7 quarters. The position peaked at $98K in Q3 2021. 17 funds tracked by Wall St. Rank hold CELUW as of Q2 2023.

  • Warberg Asset Management reported no remaining Celularity Inc position as of Q2 2023 after selling out during the quarter.
  • Warberg Asset Management sold 18,200 Celularity Inc shares in Q2 2023, an estimated $1.09K.
  • Warberg Asset Management first reported a position in Celularity Inc in Q2 2021 and held it in 7 quarters.
  • Warberg Asset Management's Celularity Inc position peaked at $98K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Celularity Inc as of Q2 2023.

Based on Warberg Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.